-
METCELA
Fibroblast-based therapies for cardiac diseases
-
Repertoire Genesis
Novel diagnostic methods / therapies based on immunodiversity analysis
Acquired by Eurofins (2022.5)
-
Myoridge
Drug discovery support tools utilizing iPS cell-derived cardiomyocytes
-
LiberoThera
Drug discovery targeting membrane proteins and related services
-
AIBIOS
Drug development for inflammatory bowel diseases develop in intestinal mucosa
-
Alchemedicine
Proprietary compound synthesis technology for Drug development platform
-
MabGenesis
Providing therapeutic monoclonal antibody drugs in human and animal territories
-
Curreio
Drug discovery and R&D using cryo-electron microscopy